Search tips
Search criteria 


Logo of bmjcrBMJ Case ReportsVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
BMJ Case Rep. 2010; 2010: bcr01.2009.1420.
Published online 2010 March 15. doi:  10.1136/bcr.01.2009.1420
PMCID: PMC3029549
Unexpected outcome (positive or negative) including adverse drug reactions

Ischaemic stroke in a patient on sunitinib


Concerns have been raised about possible theoretical risk of thrombosis and bleeding with sunitinib (anti-vascular endothelial cell growth factor agent) therapy used for treatment of metastatic renal cell carcinoma. We present the first case of stroke in an older man with metastatic renal cell carcinoma, on sunitinib therapy.

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group